Skip to main content
Scinai Immunotherapeutics Ltd. (FRA:2F5)
Germany flag Germany · Delayed Price · Currency is EUR
0.915
+0.020 (2.23%)
Last updated: Dec 5, 2025, 9:59 AM CET

Scinai Immunotherapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
 TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
 Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Net Income
5.144.8-6.5-5.8-8.21-1.39
Upgrade
Depreciation & Amortization
1.71.650.510.560.470.76
Upgrade
Loss (Gain) From Sale of Assets
------0.05
Upgrade
Asset Writedown & Restructuring Costs
---0.21--
Upgrade
Stock-Based Compensation
0.620.681.141.62.762.95
Upgrade
Other Operating Activities
-13.9-13.57-3.74-4.11-3.15-20.3
Upgrade
Change in Accounts Receivable
0.070.14-0.290.140.06-0.17
Upgrade
Change in Accounts Payable
0-0.16-0.15-0.180-4.73
Upgrade
Change in Other Net Operating Assets
0.670.13-0.360.310.640.37
Upgrade
Operating Cash Flow
-5.69-6.34-9.38-7.27-7.43-22.56
Upgrade
Capital Expenditures
-0.02-0.01-0.64-0.84-0.14-1.91
Upgrade
Sale of Property, Plant & Equipment
-----0.05
Upgrade
Other Investing Activities
-----0.01
Upgrade
Investing Cash Flow
-0.02-0.01-0.64-0.84-0.14-1.85
Upgrade
Long-Term Debt Repaid
------0.39
Upgrade
Net Debt Issued (Repaid)
------0.39
Upgrade
Issuance of Common Stock
1.591.441.096.7821.434.65
Upgrade
Other Financing Activities
22----
Upgrade
Financing Cash Flow
3.593.441.096.7821.434.27
Upgrade
Foreign Exchange Rate Adjustments
0.15-0.01-0.27-1.980.580.53
Upgrade
Net Cash Flow
-2.08-2.92-9.21-3.314.44-19.61
Upgrade
Free Cash Flow
-5.71-6.35-10.02-8.1-7.57-24.47
Upgrade
Free Cash Flow Margin
-497.38%-964.59%----
Upgrade
Free Cash Flow Per Share
-4.33-7.87-25.65-42.97-53.60-220.83
Upgrade
Cash Interest Paid
-0.140.830.92-0.01
Upgrade
Levered Free Cash Flow
-3.39-3.82-8.28-5.52-2.71-1.88
Upgrade
Unlevered Free Cash Flow
-2.6-2.93-5.9-5.52-2.71-1.66
Upgrade
Change in Working Capital
0.750.11-0.80.270.7-4.53
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.